Antisense


Journal

International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847

Informations de publication

Date de publication:
2022
Historique:
received: 18 08 2021
accepted: 09 02 2022
entrez: 28 3 2022
pubmed: 29 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

VicR is the essential response regulator related to the synthesis of exopolysaccharide (EPS) - one of the main cariogenic factors of Aminated dendritic mesoporous silica nanoparticles (DMSNs-NH DMSNs-NH DMSNs-NH

Identifiants

pubmed: 35340824
doi: 10.2147/IJN.S334785
pii: 334785
pmc: PMC8956320
doi:

Substances chimiques

Silicon Dioxide 7631-86-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1255-1272

Informations de copyright

© 2022 Tian et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Phys Chem B. 2009 Feb 12;113(6):1796-804
pubmed: 19152258
Nat Rev Microbiol. 2004 Mar;2(3):241-9
pubmed: 15083159
Curr Opin Microbiol. 2016 Oct;33:47-55
pubmed: 27375107
Small. 2009 Jun;5(12):1408-13
pubmed: 19296554
Dalton Trans. 2014 Apr 7;43(13):5142-50
pubmed: 24496286
J Dent Res. 2013 Dec;92(12):1065-73
pubmed: 24045647
J Bacteriol. 2005 Jun;187(12):4064-76
pubmed: 15937169
Biomaterials. 2016 Sep;101:207-16
pubmed: 27294538
Adv Mater. 2012 Mar 22;24(12):1504-34
pubmed: 22378538
J Appl Microbiol. 2021 Sep;131(3):1072-1082
pubmed: 33382154
Front Microbiol. 2015 Dec 21;6:1432
pubmed: 26733973
Mol Cancer Ther. 2002 Mar;1(5):347-55
pubmed: 12489851
J Drug Target. 2021 Feb;29(2):131-154
pubmed: 32815741
Curr Opin Biotechnol. 2020 Dec;66:1-10
pubmed: 32554325
Acc Chem Res. 2013 Mar 19;46(3):792-801
pubmed: 23387478
mBio. 2010 May 18;1(1):
pubmed: 20689751
ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34658-34666
pubmed: 32662625
Pharm Dev Technol. 2019 Jan;24(1):127-132
pubmed: 29357725
Acta Pharm Sin B. 2018 Mar;8(2):165-177
pubmed: 29719777
Int J Nanomedicine. 2016 May 31;11:2471-80
pubmed: 27330290
Curr Top Med Chem. 2019;19(27):2507-2523
pubmed: 31775591
J Mater Chem B. 2017 Apr 28;5(16):3012-3023
pubmed: 32263993
Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112318
pubmed: 34474869
Mol Syst Biol. 2009;5:305
pubmed: 19756044
Adv Mater. 2013 Nov 6;25(41):5981-5
pubmed: 23955990
ACS Nano. 2019 Apr 23;13(4):3754-3782
pubmed: 30908008
J Dent Res. 2020 Apr;99(4):362-373
pubmed: 32122215
Hum Gene Ther. 2019 Oct;30(10):1204-1210
pubmed: 31517544
Nanoscale. 2015 Apr 14;7(14):6173-84
pubmed: 25772672
Biomater Sci. 2016 Jan;4(1):70-86
pubmed: 26484365
Pharmaceutics. 2018 Aug 06;10(3):
pubmed: 30082647
Front Cell Infect Microbiol. 2017 Nov 14;7:474
pubmed: 29184853
ACS Nano. 2011 May 24;5(5):3568-76
pubmed: 21452883
Small. 2015 Jan 27;11(4):392-413
pubmed: 25367307
Biochemistry (Mosc). 2017 Jun;82(6):655-662
pubmed: 28601075
Adv Mater. 2020 Jun;32(23):e1907035
pubmed: 32319133
ACS Appl Mater Interfaces. 2020 Apr 22;12(16):18823-18832
pubmed: 32182415
Microbiol Spectr. 2019 Jan;7(1):
pubmed: 30657107
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
Acta Pharmacol Sin. 2014 May;35(5):592-8
pubmed: 24705100
J Mater Chem B. 2019 Feb 28;7(8):1209-1225
pubmed: 32255160
Biomed Microdevices. 2012 Apr;14(2):259-70
pubmed: 22124885
J Dent Res. 2007 Jul;86(7):606-10
pubmed: 17586705
Int J Nanomedicine. 2017 May 09;12:3577-3589
pubmed: 28533681
Appl Microbiol Biotechnol. 2018 Feb;102(3):1055-1065
pubmed: 29209794
J Dent Res. 1958 Nov-Dec;37(6):1077-87
pubmed: 13611122
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):172-182
pubmed: 27349594
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434-9
pubmed: 12397186
ACS Appl Mater Interfaces. 2015 Aug 12;7(31):17450-9
pubmed: 26192924
Small. 2010 Jun 6;6(11):1185-90
pubmed: 20461725
Pharmaceutics. 2019 Feb 13;11(2):
pubmed: 30781850
Nanomedicine. 2020 Jan;23:102094
pubmed: 31669854
Curr Issues Mol Biol. 2019;32:167-200
pubmed: 31166172
Int J Nanomedicine. 2021 Jun 30;16:4409-4430
pubmed: 34234434
Nano Lett. 2014 Feb 12;14(2):923-32
pubmed: 24467566
J Dent Res. 2020 Feb;99(2):204-213
pubmed: 31821772
Nanomedicine. 2018 Apr;14(3):745-758
pubmed: 29341934
Mol Oral Microbiol. 2016 Jun;31(3):228-33
pubmed: 26343264
Nat Rev Microbiol. 2014 Mar;12(3):181-96
pubmed: 24509783
Molecules. 2017 May 11;22(5):
pubmed: 28492505
Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):499-515
pubmed: 24154653
J Dent Res. 2018 Dec;97(13):1477-1484
pubmed: 29969955
Int J Oral Sci. 2017 Dec;9(12):e7
pubmed: 32987970
Caries Res. 2011;45(1):69-86
pubmed: 21346355
Front Microbiol. 2016 May 10;7:687
pubmed: 27242713
Front Microbiol. 2018 Oct 04;9:2365
pubmed: 30337917
Nucleic Acids Res. 2008 Oct;36(18):5955-69
pubmed: 18812398
Adv Mater. 2015 Jan 14;27(2):215-22
pubmed: 25423915
Sci Adv. 2020 Jun 19;6(25):eaaz4462
pubmed: 32596445
J Colloid Interface Sci. 2020 Feb 1;559:197-205
pubmed: 31627143

Auteurs

Yuting Tian (Y)

State Key Laboratory of Oral Diseases, Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

Yue Zhang (Y)

State Key Laboratory of Oral Diseases, Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

Mengjiao Zhang (M)

West China School of Pharmacy, Sichuan University, Chengdu, 610041, People's Republic of China.

Xianchun Chen (X)

College of Polymer Science and Engineering, Sichuan University, Chengdu, 610065, People's Republic of China.

Lei Lei (L)

State Key Laboratory of Oral Diseases, Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

Tao Hu (T)

State Key Laboratory of Oral Diseases, Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH